<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>Regenerative Therapy</title>
	<link>http://mynewtherapy.com</link>
	<description>Clinical Guide to Stem Cells &#38; Regenerative Medicine</description>
	<lastBuildDate>Mon, 06 Feb 2012 07:41:15 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.0.1" -->

	<item>
		<title>Epidermolysis bullosa treated wiith bone marrow transplantation</title>
		<description><![CDATA[&#8220;Concise review: Transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa.&#8221;
&#8220;Healthy donor cells from the hematopoietic graft migrate to the injured skin; simultaneously, there is an increase in the production of collagen type VII, increased skin integrity, and reduced tendency to blister formation.&#8221;
Tolar J, Blazar BR, Wagner JE. 
Published in:
Stem Cells. 2011 Jun;29(6):900
http://www.ncbi.nlm.nih.gov/pubmed/21557391
]]></description>
		<link>http://mynewtherapy.com/epidermolysis-bullosa-treated-by-bone-marrow-transplantation/</link>
			</item>
	<item>
		<title>Treatment of diabates type 1 by adoptive cell immune modulation</title>
		<description><![CDATA[&#8220;Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells.&#8221;
Zhao y. et al 2012 BMC Med. 10;10(1):3
&#8220;Stem Cell Educator therapy can markedly improve C-peptide levels, reduce the median glycated hemoglobin A1C (HbA1C) values, and decrease the median daily dose of insulin in patients with some residual beta cell function (n = 6) and patients with no residual pancreatic islet beta cell function (n = 6). Treatment ...]]></description>
		<link>http://mynewtherapy.com/treatment-of-diabates-type-1-by-adoptive-cell-immune-modulation/</link>
			</item>
	<item>
		<title>Storage of fat derived stem cells</title>
		<description><![CDATA[American Cryostem
The Company&#8217;s  provides  processing and cryopreservation of Adipose Derived Stem Cells  and Adipose Tissue  for autologous use.
        American CryoStem Corporation
               Red Bank, NJ USA
http://www.americancryostem.com/
]]></description>
		<link>http://mynewtherapy.com/storage-of-fat-derived-stem-cells/</link>
			</item>
	<item>
		<title>Treatment of ALS with autologous stem cells</title>
		<description><![CDATA[BrainStorm Announces Clinical Data Supporting Safety and Efficacy of NurOwn™ Based on Initial ALS Patient Results
The ALS Phase I/II human clinical trial is being performed at Hadassah Medical Center in Israel in collaboration with BrainStorm and is utilizing BrainStorm’s NurOwn™ technology for growing and modifying autologous adult human stem cells to treat ALS, often referred to as Lou Gehrig&#8217;s Disease. The study is headed by Prof. Karussis, M.D., Ph.D
http://www.brainstorm-cell.com/Index.asp?ArticleID=260&#38;CategoryID=76&#38;Page=1


]]></description>
		<link>http://mynewtherapy.com/treatment-of-als-with-autologous-stem-cells/</link>
			</item>
	<item>
		<title>Treatment of  hearing loss by cord blood stem cells</title>
		<description><![CDATA[New clinical study to treat hearing loss by cord blood stem cells has been approved by the FDA:
&#8220;Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children&#8221;
Acquired sensorineural hearing loss i children will be treated with autologous cord blood cells. The primary objective of this study is to determine the safety of autologous hUCB infusion in children with acquired hearing loss. The secondary objective is to determine if functional, physiologic and anatomic outcomes ...]]></description>
		<link>http://mynewtherapy.com/treatment-of-hearing-loss-by-cord-blood-stem-cells/</link>
			</item>
	<item>
		<title>Diabetes type1 treatment by ex vivo immune modulation</title>
		<description><![CDATA[Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells
Yong Zhao, Zhaoshun Jiang, Tingbao Zhao, Mingliang Ye, Chengjin Hu, Zhaohui Yin, Heng Li, Ye Zhang, Yalin Diao, Yunxiang Li, Yingjian Chen, Xiaoming Sun, Mary Beth Fisk, Randal Skidgel, Mark Holterman, Bellur Prabhakar and Theodore Mazzon
BMC Medicine 2012, 10:3  http://www.biomedcentral.com/1741-7015/10/3/abstract
&#8220;A procedure for Stem Cell Educator therapy in which a patient&#8217;s blood is circulated through a closed-loop system that separate lymphocytes from the whole blood and briefly co-cultures them with adherent CB-SCs before returning them ...]]></description>
		<link>http://mynewtherapy.com/diabetes-type1-treatment-by-ex-vivo-immune-modulation/</link>
			</item>
	<item>
		<title>Primary immunodeficiency treated with cord blood transplantation</title>
		<description><![CDATA[Outcome of unrelated umbilical cord blood transplantation in 88 patients with primary immunodeficiency in Japan.
Morio T, Atsuta Y, Tomizawa D, Nagamura-Inoue T, Kato K, Ariga T, Kawa K, Koike K, Tauchi H, Kajiwara M, Hara T, Kato S; Japanese Cord Blood Bank Network.
Department of Paediatrics and Developmental Biology, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Tokyo, Japan.
&#8220;Umbilical cord blood transplantation (UCBT) performed in 88 patients with primary immunodeficiency (PID) between ...]]></description>
		<link>http://mynewtherapy.com/primary-immunodeficiency-treated-with-cord-blood-transplantation/</link>
			</item>
	<item>
		<title>Adoptive cell therapy for metastatic melanoma patients</title>
		<description><![CDATA[Adoptive cell therapy for metastatic melanoma patients
Adoptive cell therapy is provided as experimental treatment for metastatic melanoma patients at the Ella Institute, the Sheba Medical Center, Israel.
Along with other advanced technologies, eligible patients are offered the advanced immunotherapy treatment with TIL (tumor infiltrating lymphocytes).This treatment was developed at the National Institute of Health, US, and very encouraging clinical results have been published by both institutions in the US and Israel*.
*
1. Clin Cancer Res. 2011 17:4550-7.
Durable ...]]></description>
		<link>http://mynewtherapy.com/adoptive-cell-therapy-for-metastatic-melanoma-patients/</link>
			</item>
	<item>
		<title>Cord blood transplantation for neurological and metabolic diseases</title>
		<description><![CDATA[Cord blood transplantation for neurological and metabolic diseases
Presentation by Dr. Joanne Kurtzberg
http://ash.eventmediasite.com/media/127_3/index.htm

]]></description>
		<link>http://mynewtherapy.com/cord-blood-transplantation-for-neurological-diseases/</link>
			</item>
	<item>
		<title>Bone Marrow Transplant Compared to Mobilized Peripheral Blood</title>
		<description><![CDATA[A new study finds that mobilized peripheral blood stem cells convey no survival advantage over bone marrow transplants when the donor is not an HLA-identical sibling of the recipient. 
Interview at the annual meeting of the American Society of Hematology &#8211;  December 2011 
http://www.youtube.com/watch?v=jHfCqV4Xt4s
&#8220;Two-year overall survival among 273 patients randomized to receive filgrastim (Neupogen)-mobilized peripheral blood stem cells (PBSC) from an unrelated donor was 51% in an intention-to-treat analysis, compared with 46% of 278 patients randomized to ...]]></description>
		<link>http://mynewtherapy.com/bone-marrow-transplant-compared-to-mobilized-peripheral-blood/</link>
			</item>
</channel>
</rss>

